Biocon Ltd.'s disappointing Q3FY25 performance was largely due to exceptional items, with adjusted net profit standing at Rs 13 crore, and revenue growth of 7% on a like-for-like basis.
As far as revenue guidance of 15% is concerned, L&T is keeping pace with the guidance with a couple of months to go, R Shankar Raman says in a post-earnings conference call.
Tata Consumer Products Ltd. has reported a mixed Q3FY25 performance, with revenue growth driven by strong sales in the India business, but Ebitda margins contracting due to higher commodity costs.
The market will likely continue to be driven by volatility due to the budget and the Reserve Bank of India's monetary-policy-committee meeting next week.